Leti, innovation
for industry
Home
>How to collaborate
>Success stories
> Creation of startups in 2008Creation of startups in 2008
Fluoptics’ technology improves cancer detection
Combining technologies developed with Leti and the Université Joseph Fourier in Grenoble, Fluoptics produced an innovative system of optical imaging for surgery involving certain cancers. Its imaging devices and fluorescent markers specifically target cancerous tumors, enabling better detection and improving surgery to remove them.
The incubation of the company in Leti allowed the finalization of the prototype laboratory and its validation by surgeons who specialize in cancer.
“The total immersion of our team in our partners’ research allowed an easy transfer of their expertise and know-how from the project’s beginning to our launch.”
Odile Allard
Fluoptics CEO
Visit the Fluoptics website
Fluoptics expects to commercialize its FluoBeam instrument in 2009 for preclinical research and will begin the phases of homologation of its first fluorescent marker.
Kalray targets high-end markets with programmable chips
Launched in July 2008 as a joint project of Leti and its sister lab in Saclay, CEA-LIST, Kalray designs massively parallel processors for small to mid-size production series of high-end embedded systems in the fields of industrial and professional electronics.
Kalray’s products support applications requiring high processing power along with low power consumption, high flexibility of programming and a short time to market. Examples include
- high-bandwidth communication infrastructures,
- broadcast and video surveillance equipment,
- high-end control applications,
- high-end industrial applications…
"Kalray is differentiated by our products’ low power consumption and higher programming flexibility and by the unique technological ecosystem of the CEA joint laboratory as well as its location close to the design centers of our major targeted customers."
Joël Monnier
Kalray CEO
Kalray, which raised 2.5 million Euros in a first round of financial backing, has a long-term R&D agreement for a joint laboratory with Leti and a licensing agreement for to use a portfolio of 20 patents.
MORE :
|
|